<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">  <id>83bee69b-7f12-4662-a0b3-0644958d6972</id>  <name>Addiction and Mental Health Agitated Patient Order Group</name>  <description>    <lifecycle_state>Initial</lifecycle_state>    <details>      <purpose/>      <use/>      <misuse/>    </details>    <other_details>      <item>        <key>MetaDataSet:Sample Set </key>        <value>Template metadata sample set </value>      </item>      <item>        <key>Acknowledgements</key>        <value/>      </item>      <item>        <key>Business Process Level</key>        <value/>      </item>      <item>        <key>Care setting</key>        <value/>      </item>      <item>        <key>Client group</key>        <value/>      </item>      <item>        <key>Clinical Record Element</key>        <value/>      </item>      <item>        <key>Copyright</key>        <value/>      </item>      <item>        <key>Issues</key>        <value/>      </item>      <item>        <key>Owner</key>        <value/>      </item>      <item>        <key>Sign off</key>        <value/>      </item>      <item>        <key>Speciality</key>        <value/>      </item>      <item>        <key>User roles</key>        <value/>      </item>    </other_details>  </description>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">    <items>      <item>        <key>Technical.ï»© Technical Traceability</key>        <value>{~AHSID~83bee69b-7f12-4662-a0b3-0644958d6972~NAME~Addiction and Mental Health Agitated Patient Order Group}</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;- Once any restraint is applied, it must be decreased and discontinued at the earliest and safest opportunity.&lt;br&gt;- An authorized health care professional must re-assess the patient within fifteen (15) minutes of the application of any restraint and at least every two (2) hours thereafter&lt;br&gt;&amp;nbsp;&lt;br&gt;Please see policy document(s) for further details&lt;br&gt;&lt;u&gt;&lt;strong&gt;- Restraint as a Last Resort Policy - AMH&lt;br&gt;- Restraint as a Last Resort Policy &lt;/strong&gt;&lt;/u&gt;(URL:&amp;nbsp;https://extranet.ahsnet.ca/teams/policydocuments/1/clp-prov-restraint-hcs-176.pdf)&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Restraint as a Last Resort - Addiction and Mental Health Inpatient; As needed&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Clinical Notes</key>        <value>&lt;p&gt;Would the Restraint as a last resort - Inpatient order be more appropriate?&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Rationale: Behavioral emergency; Care/treatment plan in non-emergency situation&lt;/p&gt;&lt;p&gt;Restraint Type:&lt;/p&gt;&lt;p&gt;Mechanical (Waist and trunk, Rear fastening seatbelt, Limb restraint, Table top or chair tray, Full-length side rails, Chairs that patient cannot get out of, Other);&lt;/p&gt;&lt;p&gt;Environmental (Seclusion room, Locked doors, Half doors, Wander Management System, Other);&lt;/p&gt;&lt;p&gt;Pharmacologic (Regularly Scheduled, PRN, Once);&lt;/p&gt;&lt;p&gt;Physical (Hands on holding, Moving patient to another location against their will)&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Nursing Communication; All mechanical restraints must be monitored as per policy, See hyperlink for policy&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Clinical Notes</key>        <value>&lt;p&gt;Order not required&lt;/p&gt;&lt;p&gt;Contenf found on Resource tab - AHS policies/procedures then search for the policy&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Nursing Communication; Involve Protective Services as needed&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Clinical Notes</key>        <value>&lt;p&gt;Order not required&lt;/p&gt;</value>      </item>    </items>  </annotations>  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Addiction and Mental Health Agitated Patient">    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2a1ae21f-3580-4b82-b77e-a11ffc006cd2" concept_name="PC Restraint as a last resort- Addiction and Mental health inpatient Order" max="1" path="/items" name="Restraint as a Last Resort - Addiction and Mental Health Inpatient; As needed"/>    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="PC Nursing Communication Order" max="1" path="/items" name="Nursing Communication; All mechanical restraints must be monitored as per policy, See hyperlink for policy"/>    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="PC Nursing Communication Order" max="1" path="/items" name="Nursing Communication; Involve Protective Services as needed"/>    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Medications">      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="35f4467d-377f-4566-9ac3-01a0af1537d1" concept_name="PHARM haloperidol Tablet Order" max="1" path="/items" name="haloperidol tablet; 5 mg, oral, every 2 hours, as needed, agitation, Maximum 20 mg per 24 hours."/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2d22d5b2-02b0-42ed-9870-188ce381b761" concept_name="PHARM haloperidol injection Order" max="1" path="/items" name="haloperidol injection; 5 mg, intramuscular, every 2 hours, as needed, agitation, Maximum 20 mg per 24 hours."/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="140d43f0-65b4-4046-95fd-c717db3804a6" concept_name="PHARM QUEtiapine Tablet Order" max="1" path="/items" name="QUEtiapine tablet; 100 mg, oral, every 2 hours, as needed, agitation"/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c640cdd5-18b1-419e-a352-4c37c29fc4b0" concept_name="PHARM OLANZapine Oral disintegrating tablet Order" max="1" path="/items" name="OLANZapine tablet orally disintegrating; 5 mg, oral, every 2 hours, as needed, agitation, Use caution when combining with benzodiazepines. Maximum 20 mg per 24 hours for all routes.  See monograph for guidance."/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="581d8ac7-3660-49d3-b3e9-644b992a8d4b" concept_name="PHARM OLANZapine tartrate injection Order" max="1" path="/items" name="OLANZapine injection; 5 mg, intramuscular, every 2 hours, as needed, agitation, Use caution when combining with benzodiazepines. Maximum 20 mg per 24 hours for all routes.  See monograph for guidance."/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="21232e19-e1e1-4688-9dba-6570ab9dcf43" concept_name="PHARM LORazepam Tablet Order" max="1" path="/items" name="LORazepam tablet; 2 mg, oral, every 2 hours, as needed, agitation"/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2a303131-9a71-41ff-ba2e-991d423d3ca1" concept_name="PHARM LORazepam Sublingual tablet Order" max="1" path="/items" name="LORazepam tablet sublingual; 1 mg, sublingual, every hour, as needed, agitation"/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="7a23625d-05f5-4b17-bbb4-dd5c29dd135b" concept_name="PHARM LORazepam injection Order" max="1" path="/items" name="LORazepam IV/IM/SC; 2 mg, intramuscular, every 2 hours, as needed, agitation"/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71157fbf-6520-415d-a737-00b4745b49b0" concept_name="PHARM loxapine Tablet Order" max="1" path="/items" name="loxapine tablet; 25 mg, oral, every 4 hours, as needed, agitation, Maximum 200 mg per 24 hours."/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="badbaea4-bc04-4df1-8098-3aeb16c52d37" concept_name="PHARM zuclopenthixol acetate Depot injection Order" max="1" path="/items" name="zuclopenthixol acetate Depot injection; 100 mg, intramuscular, every 72 hours, as needed, agitation, See monograph for ongoing management."/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="192a9d25-5a9c-4241-be19-1493bad7eb39" concept_name="PHARM benztropine Tablet Order" max="1" path="/items" name="benztropine tablet; 1 mg, oral, every 8 hours, as needed, agitation, Maximum 6 mg per 24 hours."/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>    </Item>    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>  </definition>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1">    <digest id="MD5-CAM-1.0.1">5DC6E2FC9E91ADD05E7C5B3E06F83D23</digest>  </integrity_checks></template>